Profile data is unavailable for this security.
About the company
Guardion Health Sciences, Inc. is a clinical nutrition company. The Company offers a portfolio of science-based, clinically supported products designed to support the health needs of consumers, healthcare professionals and providers and their patients. The Company sells two ocular products: GlaucoCetin and Lumega-Z. GlaucoCetin is a dietary supplement in a capsule form designed specifically to provide nutrients to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health. Lumega-Z, its medical food product, has a formula designed to replenish and restore the macular protective pigment, simultaneously delivering critical and essential nutrients to the eye. As a medical food, Lumega-Z must be administered under the supervision of a physician or professional healthcare provider. It sells GlaucoCetin and Lumega-Z on its Website, guardionhealth.com.
- Revenue in USD (TTM)12.06m
- Net income in USD-5.12m
- Incorporated2015
- Employees9.00
- LocationGuardion Health Sciences Inc2925 Richmond Avenue, Suite 1200HOUSTON 77098United StatesUSA
- Phone+0 (1800) 873-5141
- Fax+1 (858) 630-5543
- Websitehttps://www.guardionhealth.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lotus Pharmaceuticals Inc | 70.79m | 1.72m | 8.08m | 233.00 | 0.0542 | 0.0008 | 2.09 | 0.1142 | 0.0553 | 0.0553 | 2.56 | 3.58 | 0.6321 | 37.27 | 17.85 | 303,836.90 | 1.55 | 22.84 | 1.71 | 26.40 | 35.10 | 41.62 | 2.45 | 19.93 | 0.4428 | 30.80 | 0.0516 | 0.00 | 28.71 | 31.70 | -12.22 | 51.11 | 70.48 | -- |
| CV Sciences Inc | 15.86m | -3.23m | 8.18m | 42.00 | -- | 3.46 | -- | 0.5157 | -0.0207 | -0.0207 | 0.1012 | 0.0145 | 1.59 | 1.42 | 27.25 | 377,571.40 | -32.43 | -43.42 | -83.71 | -77.75 | 45.13 | 51.81 | -20.38 | -45.68 | 0.2677 | -13.32 | 0.0472 | -- | -1.24 | -19.80 | 133.96 | -20.87 | -- | -- |
| Bon Natural Life Ltd | 29.52m | 4.60m | 8.18m | 96.00 | 0.4128 | 0.0682 | 1.49 | 0.2771 | 4.99 | 4.99 | 32.10 | 30.23 | 0.7045 | 15.27 | 5.19 | 307,524.60 | 10.86 | 14.04 | 13.69 | 20.68 | 29.94 | 30.00 | 15.42 | 17.62 | 2.41 | 30.54 | 0.0955 | 0.00 | -1.29 | 22.32 | -26.32 | 83.09 | -6.70 | -- |
| DH Enchantment Inc | 680.00 | -156.15k | 8.31m | 1.00 | -- | -- | -- | 12,225.15 | -0.0002 | -0.0002 | 0.00 | -0.0012 | 0.0715 | 0.9437 | 45.33 | 680.00 | -1,641.09 | -- | -- | -- | -60.29 | -- | -22,963.23 | -- | 0.0032 | -13.28 | -- | -- | -95.43 | -- | 59.53 | -- | -- | -- |
| Tonix Pharmaceuticals Holding Corp | 10.25m | -98.59m | 9.60m | 103.00 | -- | 0.0117 | -- | 0.9366 | -177.41 | -177.41 | 9.46 | 46.94 | 0.0652 | -- | -- | 99,514.56 | -62.71 | -59.46 | -70.20 | -65.92 | 37.55 | -- | -961.87 | -5,126.73 | 0.8666 | -- | 0.0767 | -- | -- | -- | 0.1874 | -- | 320.57 | -- |
| Coeptis Therapeutics Holdings Inc | 0.00 | -16.31m | 9.65m | 5.00 | -- | 2.17 | -- | -- | -0.5804 | -0.5804 | 0.00 | 0.1197 | 0.00 | -- | -- | 0.00 | -212.70 | -36.90 | -378.58 | -37.81 | -- | -- | -- | -- | -- | -- | 0.349 | -- | -- | -- | 43.40 | -- | -- | -- |
| Silo Pharma Inc | 72.12k | -3.53m | 10.40m | 3.00 | -- | 1.24 | -- | 144.26 | -1.18 | -1.20 | 0.024 | 1.87 | 0.008 | -- | -- | 24,040.00 | -39.26 | -24.90 | -43.11 | -26.39 | 91.90 | 82.79 | -4,889.57 | -2,757.85 | -- | -- | 0.00 | -- | 0.00 | -- | 7.07 | -- | -- | -- |
| Healthy Extracts Inc | 2.56m | -2.76m | 11.11m | -- | -- | 73.29 | -- | 4.34 | -0.9512 | -0.9512 | 0.8819 | 0.0512 | 0.9428 | 0.5035 | 32.10 | -- | -101.47 | -53.78 | -375.65 | -146.65 | 68.46 | 45.68 | -107.63 | -87.53 | 0.1293 | -2.22 | 0.879 | -- | 10.41 | 105.93 | -151.54 | -- | -- | -- |
| Guardion Health Sciences Inc | 12.06m | -5.12m | 12.29m | 9.00 | -- | 3.60 | -- | 1.02 | -4.00 | -4.00 | 9.49 | 2.66 | 0.9718 | 2.63 | 5.96 | 1,340,280.00 | -41.26 | -77.90 | -47.92 | -86.55 | 43.43 | 42.45 | -42.46 | -176.93 | 6.49 | -4.24 | 0.00 | -- | 10.85 | 67.03 | 101.00 | -- | -58.56 | -- |
| Allied Corp | 98.65k | -7.73m | 14.19m | -- | -- | -- | -- | 143.84 | -0.0776 | -0.0776 | 0.001 | -0.0726 | 0.0234 | 1.55 | 0.5284 | -- | -183.13 | -- | -- | -- | -1,452.53 | -- | -7,835.49 | -- | 0.0382 | -8.18 | -- | -- | -56.46 | -- | 31.30 | -- | -- | -- |
| Talphera Inc | 651.00k | -14.31m | 15.05m | 15.00 | -- | 0.9215 | -- | 23.12 | -0.8945 | -0.8863 | 0.0368 | 0.9612 | 0.0237 | -- | -- | 43,400.00 | -51.96 | -22.60 | -67.70 | -28.55 | -- | -- | -2,197.39 | -714.87 | -- | -- | 0.00 | -- | -- | -21.26 | -119.16 | -- | -34.33 | -- |
| NDT Pharmaceuticals Inc | -100.00bn | -100.00bn | 16.00m | 1.00 | -- | 0.0893 | -- | -- | -- | -- | -- | 1.12 | -- | -- | -- | -- | -- | -164.47 | -- | -452.47 | -- | -- | -- | -6,891.36 | -- | -- | 0.00 | -- | -100.00 | -- | 87.56 | -- | -- | -- |
| Aytu Biopharma Inc | 93.76m | -13.68m | 16.13m | 150.00 | -- | 0.4885 | -- | 0.172 | -2.65 | -2.65 | 18.21 | 5.53 | 0.6792 | 2.42 | 2.93 | 625,053.30 | -9.91 | -33.56 | -25.58 | -52.81 | 65.32 | 56.89 | -14.60 | -73.81 | 0.6923 | 0.216 | 0.352 | -- | 11.10 | 96.56 | 84.33 | -- | -- | -- |
| Polypid Ltd | 0.00 | -24.25m | 16.60m | 59.00 | -- | 2.32 | -- | -- | -12.35 | -12.35 | 0.00 | 1.49 | 0.00 | -- | -- | 0.00 | -84.94 | -76.92 | -120.03 | -89.61 | -- | -- | -- | -- | -- | -28.72 | 0.5498 | -- | -- | -- | 39.67 | -- | -42.34 | -- |
Data as of Jul 26 2024. Currency figures normalised to Guardion Health Sciences Inc's reporting currency: US Dollar USD
5.14%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Renaissance Technologies LLCas of 31 Mar 2024 | 37.82k | 2.95% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 14.85k | 1.16% |
| BlackRock Fund Advisorsas of 31 Mar 2024 | 10.03k | 0.78% |
| UBS Securities LLCas of 31 Mar 2024 | 1.17k | 0.09% |
| Tower Research Capital LLCas of 31 Mar 2024 | 998.00 | 0.08% |
| Morgan Stanley & Co. LLCas of 31 Mar 2024 | 659.00 | 0.05% |
| Citigroup Global Markets, Inc. (Investment Management)as of 31 Mar 2024 | 373.00 | 0.03% |
| Cornerstone Planning Group LLCas of 31 Mar 2024 | 37.00 | 0.00% |
| Desjardins Securities, Inc.as of 31 Mar 2024 | 17.00 | 0.00% |
| Wells Fargo Bank, NA (Private Banking)as of 31 Mar 2024 | 8.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
